Back to 
BlackRock, Inc.
BlackRock, Inc.
ERNA
1 quarters
Position history for BlackRock, Inc.'s holdings in Ernexa Therapeutics Inc.
Yes. BlackRock holds 33 shares of ERNA (Ernexa Therapeutics), worth $219, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$219
Current Shares
33
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ERNA: Citadel Advisors LLC, Vanguard Fiduciary Trust Co., Geode Capital Management, LLC, Vanguard Capital Management LLC, Citigroup Inc.